Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained IOP Elevation or Ocular Hypotensive Treatment

IMPORTANCE: For the management of retinal disease, use of intravitreous injections of anti-vascular endothelial growth factor has increased. Recent reports have suggested that this therapy may cause persistent intraocular pressure (IOP) elevation and potentially increase the risk of glaucoma in pati...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Ophthalmol
Autori principali: Bressler, Susan B., Almukhtar, Talat, Bhorade, Anjali, Bressler, Neil M., Glassman, Adam R., Huang, Suber S., Jampol, Lee M., Kim, Judy E., Melia, Michele
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496789/
https://ncbi.nlm.nih.gov/pubmed/25719991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2015.186
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi